Prostate Cancer

Clinician-Referred Vigorous Exercise Good for Prostate Cancer Patients

Clinician-Referred Vigorous Exercise Good for Prostate Cancer Patients

Clinician referral to a 12-week program ups vigorous exercise levels and improves mental health.

Monitor Older Men on ADT for Diabetes and CVD

Monitor Older Men on ADT for Diabetes and CVD

Prolonged androgen deprivation treatment ups risk in older men with prostate cancer, especially those with comorbidities.

Prostate Cancer-Obesity Link Stronger in Blacks

Prostate Cancer-Obesity Link Stronger in Blacks

By

Obesity is associated with greater risk of PCa among African-American men compared to non-Hispanic white men.

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

Aspirin Use Does Not Improve Prostate Cancer Mortality

Aspirin Use Does Not Improve Prostate Cancer Mortality

Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer.

Repeat Prostate Biopsies Find Significant Cancers

Repeat Prostate Biopsies Find Significant Cancers

Increased likelihood of prostate cancer seen with fourth repeat biopsy, men.

Prostate Cancer Blood Test May Avert Biopsies

Prostate Cancer Blood Test May Avert Biopsies

By

The Prostate Health Index improves detection of clinically significant prostate cancer.

Time to PCa Metastasis Affects Overall Survival

Time to PCa Metastasis Affects Overall Survival

By

Median time to death was shortest in men with metastatic disease at diagnosis.

PCa Recurrence Not Linked to Metabolic Syndrome

PCa Recurrence Not Linked to Metabolic Syndrome

By

High LDL cholesterol and high blood glucose, however, did increase the risk of PSA relapse.

Fish Oil Might Reduce Chemo's Effectiveness

Fish Oil Might Reduce Chemo's Effectiveness

Research raises concern about the simultaneous use of chemotherapy and fish oil.

Androgen Deprivation Therapy Impairs Physical Function

Androgen Deprivation Therapy Impairs Physical Function

Physical side effects seen over first 12 months of androgen deprivation therapy (ADT) persisted or worsened over 3 years of follow-up.

Intermediate-Risk Prostate Cancer Varies in Prognosis

Intermediate-Risk Prostate Cancer Varies in Prognosis

By

Researchers conclude that intermediate-risk PCa be stratified into favorable or unfavorable risk subgroups.

PSA Rising While on Abiraterone? Taking It with Food May Help

PSA Rising While on Abiraterone? Taking It with Food May Help

By

In a small study of mCRPC patients, the median time on therapy increased by nearly 100 days and PSA declined in some subjects.

Preoperative MRI May Benefit Some Prostate Surgery Patients

Preoperative MRI May Benefit Some Prostate Surgery Patients

By

Imaging was associated with a lower risk of positive surgical margins in men with cT1 prostate tumors, but not in other subgroups.

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Within 10 years of surgery, men younger than 60 years are more likely to die from prostate cancer than from other causes.

Return to Full Potency Rare After Prostate Surgery

Return to Full Potency Rare After Prostate Surgery

Only 6.7% of men reported erections that were as good after radical prostatectomy, as before—much lower than would be expected by IIEF-5 scores.

Prostate Cancer Recurrence Risk After Surgery Higher in Smokers

Prostate Cancer Recurrence Risk After Surgery Higher in Smokers

By

Even patients who quit smoking less than 10 years after radical prostatectomy are at increased risk.

Statins Promising for Cancers

Statins Promising for Cancers

By

Studies suggest that these cholesterol-lowering drugs can improve treatment of genitourinary cancers and prevent contrast-induced nephropathy.

Low Testosterone After ADT Linked with Improved Survival

Low Testosterone After ADT Linked with Improved Survival

By

Low serum testosterone levels within the first year of androgen-deprivation therapy (ADT) is associated with improved cause-specific survival.

Factors Affecting Treatment Regret in Prostate Cancer

Factors Affecting Treatment Regret in Prostate Cancer

The researchers found that 12% of the participants experienced treatment decisional regret.

CVD Risk Increased in Patients on Androgen Deprivation Therapy for Prostate Cancer

CVD Risk Increased in Patients on Androgen Deprivation Therapy for Prostate Cancer

Highest risk during first 6 months of ADT among men who had cardiovascular events before treatment.

Fatal Prostate Cancer Not Associated with Vitamin D

Fatal Prostate Cancer Not Associated with Vitamin D

Also, no significant associations found between vitamin D-related SNPs and fatal prostate cancer

Low-Grade Prostate Cancers Rarely Metastasize

Low-Grade Prostate Cancers Rarely Metastasize

By

In a study, not a single case of metastatic disease developed among 449 men who had a tumor grade of Gleason 6 or less at radical prostatectomy.

PCa Family History May Raise Breast Cancer Risks

PCa Family History May Raise Breast Cancer Risks

Doctors should ask women about the medical history of their first-degree male relatives, researchers say

IMRT Used Less in Black Prostate Cancer Patients

IMRT Used Less in Black Prostate Cancer Patients

By

African American patients are less likely than Caucasians to receive intensity-modulated radiation therapy for localized prostate cancer.

Metformin May Reduce Prostate Cancer Recurrence Risk

Metformin May Reduce Prostate Cancer Recurrence Risk

By

Meta-analysis shows that use of medication is associated with an 18% lower risk.

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose-rate brachytherapy boost (LDR-PB) achieves better rates of biochemically disease-free outcomes in prostate cancer.

Nerve Wrap May Hasten Potency Return

Nerve Wrap May Hasten Potency Return

By

The average time to return of continence and potency following prostatectomy was significantly shorter in the allograft than no-allograft group.

Sign Up for Free e-newsletters